Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

7 results

  • Increased risk of type 2 diabetes among the siblings of patients with schizophrenia
  • Mao-Hsuan Huang, Mu-Hong Chen, Kai-Lin Huang, Ju-Wei Hsu, Ya-Mei Bai, Chih-Ming Cheng, Tung-Ping Su, Cheng-Ta Li, Shih-Jen Tsai, Wei-Chen Lin, Albert C. Yang, Tzeng-Ji Chen
  • Journal: CNS Spectrums / Volume 24 / Issue 4 / August 2019
  • Published online by Cambridge University Press: 03 January 2019, pp. 453-459
  • View abstract
    Background

    Research suggests an association between metabolic disorders, such as type 2 diabetes mellitus (T2DM), and schizophrenia. However, the risk of metabolic disorders in the unaffected siblings of patients with schizophrenia remains unclear.

    Methods

    Using the Taiwan National Health Insurance Research Database, 3135 unaffected siblings of schizophrenia probands and 12,540 age-/sex-matched control subjects were included and followed up to the end of 2011. Individuals who developed metabolic disorders during the follow-up period were identified.

    Results

    The unaffected siblings of schizophrenia probands had a higher prevalence of T2DM (3.4% vs. 2.6%, p = 0.010) than the controls. Logistic regression analyses with the adjustment of demographic data revealed that the unaffected siblings of patients with schizophrenia were more likely to develop T2DM (odds ratio [OR]: 1.39, 95% confidence interval [CI]: 1.10–1.75) later in life compared with the control group. Moreover, only female siblings of schizophrenia probands had an increased risk of hypertension (OR: 1.47, 95% CI: 1.07–2.01) during the follow-up compared with the controls.

    Discussion

    The unaffected siblings, especially sisters, of schizophrenia probands had a higher prevalence of T2DM and hypertension compared with the controls. Our study revealed a familial link between schizophrenia and T2DM in a large sample. Additional studies are required to investigate the shared pathophysiology of schizophrenia and T2DM.

  • 10 - Public Nuisance
  • Edited by David A. Dana, Northwestern University, Illinois
  • Book: The Nanotechnology Challenge
  • Published online: 05 December 2011
  • Print publication: 14 November 2011, pp 225-249
  • View extract

    Summary

    We live in a chemical soup. On a daily basis, each of us is exposed to hundreds of chemicals, the vast majority of which have been subject to little or no testing to determine whether they are toxic to humans or the environment. Many of these chemicals will turn out to be harmless, but others will have detrimental or even devastating effects that will become apparent only with the passage of time. By introducing thousands of new substances whose health and environmental effects are poorly understood, if at all, nanotechnology will only add to the complexity of this chemical soup.

    The problem of toxic ignorance is widely recognized, yet legislatures, regulatory agencies, courts, and the chemical industry have done relatively little to address the problem. Without analyzing the risks posed by chemicals before they become widely distributed, it is difficult to determine the precautions that should be taken or the scope of any health and environmental problems that may result. Experiences in which we have discovered the hazards of chemical substances belatedly – ranging from asbestos to benzene to polychlorinated biphenyls (PCBs) – illustrate the potentially broad and serious consequences of toxic ignorance.